학술논문
ASO Author Reflections: Which was the Better Regimen (Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1) as Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma (R/BR-PDAC)?
Document Type
Article
Author
Source
In: Annals of Surgical Oncology . (Annals of Surgical Oncology, July 2024, 31(7):4702-4703)
Subject
Language
English
ISSN
15344681
10689265
10689265